Oxymatrine Synergizes with 5-fluorouracil to Inhibit the Proliferationof A549 Cells by Targeting APE1

CURRENT MEDICINAL CHEMISTRY · Published 2026-07-25 · DOI 10.2174/0109298673464620260714103900

Authors (5)

Guofang Zeng, Fei Luo, Qiaoli Zeng, Zhiqiang Wang, Runmin Guo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zeng, G., Luo, F., Zeng, Q., et al. (2026). Oxymatrine Synergizes with 5-fluorouracil to Inhibit the Proliferationof A549 Cells by Targeting APE1. CURRENT MEDICINAL CHEMISTRY. https://doi.org/10.2174/0109298673464620260714103900

Related articles

• EGFR Dysregulation in Cancer: From Molecular Mechanisms andKey Mutations to Evolving TKI Strategies and Resistance Mitigation · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Exploring the Therapeutic Potential of Mangiferin in Promoting Health Span and Stress Tolerance in C. elegans · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Organ Injury, Protection and Interactions: Novel Targets, Drugs,and Mechanisms · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Proteome-Wide Mendelian Randomization Identifies Novel Plasma Protein Targets in Osteoarthritis · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Causal Relationship between Obesity-related Indicators and Major PeripheralVascular Diseases: Two-sample and Multivariate MendelianRandomization Studies · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Identification of COX7B, GLRX5, and OR52H1 as VascularEndothelial Injury-associated Biomarkers in Gestational DiabetesMellitus · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Novel Insights into the Causal Effects of Plasma Protein-to-protein Ratios on Aneurysms and the Mediating Effects of Cardiometabolic Traits · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• DHRS2 as a Novel Thalidomide Target Regulating Mitophagyand Inflammation in Head and Neck Squamous Cell Carcinoma · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Biosynthesis of Nimbin and the Metabolic Pathway: A Focus on itsAntiviral Properties · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Integrating Methylation Signature Modifications and Subtype Classification into a Prognostic Risk Model for Survival Prognosis and Predicting Immunotherapy Response in Colorectal Cancer · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal